Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir in HIV/HCV-co-infected Patients Under Treatment for Genotype 1 Chronic Hepatitis C.

NCT01818856 is registered in ClinicalTrials.gov with Hospitales Universitarios Virgen del Rocío as lead sponsor.

NCT NCT01818856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01818856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir in HIV/HCV-co-infected Patients Under Treatment for Genotype 1 Chronic Hepatitis C.
Lead sponsor
Hospitales Universitarios Virgen del Rocío
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
April 30, 2013
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic, hiv infection